Fierce Pharma
AUGUST 28, 2023
It’s a sale. Two months after Abcam launched a strategic review of the company, the British antibody research expert has revealed that it’s being bought by Danaher. | Danaher Corporation is picking up all outstanding shares of Abcam for $24 apiece. Both companies’ boards unanimously approved the decision, Danaher and Abcam said Monday. The deal is expected to close in mid-2024.
MedCity News
AUGUST 28, 2023
In a new lawsuit, Bon Secours Mercy Health Virginia alleges that Anthem Health Plans of Virginia owes the health system more than $93 million in outstanding unpaid and underpaid claims. The post Bon Secours Mercy Health Sues Anthem Health Plans of Virginia for Unpaid Claims appeared first on Above the Law.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
AUGUST 28, 2023
With seven posters and nine presentations on Farxiga over the weekend at the European Society of Cardiology (ESC) scientific sessions in Amsterdam, AstraZeneca made it clear that it has lots to say | As AstraZeneca's Farxiga has added four indications over the last five years—on top of its initial 2014 approval for Type 2 diabetes—its spillover benefits have become apparent and yielded a better understanding of the interconnections between Type 2 diabetes, heart failure and chronic kidney d
MedCity News
AUGUST 28, 2023
Team-based primary care is needed now more than ever as our “on-demand” and mobile lives, complicated by a primary care shortage crisis, have led to a more transactional and fragmented healthcare experience.
Fierce Pharma
AUGUST 28, 2023
Echoing an earlier move in the United Arab Emirates, CDMO National Resilience is again growing its presence in the Middle East. | CDMO National Resilience the latest drugmaker to set down roots in Saudi Arabia, following in the footsteps of Sanofi and Merck KGaA.
MedCity News
AUGUST 28, 2023
Although many employers and consumers don’t understand the difference between value-based care and fee-for-service, most are in favor of value-based care after being given the definition, a new survey found.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 28, 2023
As the debate over worker misclassification rages, it’s important that healthcare professionals know the facts. Staffing agencies that designate their nurses as independent contractors avoid the costs of employment-related benefits like insurance, workers’ compensation, and overtime pay. These agencies also lack necessary clinical and professional oversight over their contractors, which increases the risk of substandard care.
Fierce Pharma
AUGUST 28, 2023
It’s been well documented how Novo Nordisk has had difficulty in meeting the soaring demand for its GLP-1 weight loss treatments. | Amid supply problems, Novo Nordisk plans to launch its GLP--1 drugs in “more and more” countries, CEO Lars Fruergaard Jørgensen said at a recent Reuters event, though he added that the launches will be "constrained.
MedCity News
AUGUST 28, 2023
For the August episode, we discuss some recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Andrew Trister, who just became Verily’s chief scientific officer.
Fierce Pharma
AUGUST 28, 2023
As Alnylam persists in its COVID-19 patent litigation, the RNAi specialist has been dealt a blow in one of its lawsuits against Moderna. | As Alnylam persists in its COVID-19 patent litigation, the RNAi specialist has been dealt a blow in one of its lawsuits against Moderna. But Alnylam says it'll appeal the recent ruling.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
AUGUST 28, 2023
A Bayer cell therapy for Parkinson’s disease has met primary and secondary goals of its first test in humans, and the pharmaceutical giant is now planning for a larger Phase 2 clinical trial expected to begin enrollment in the first half of next year.
Fierce Pharma
AUGUST 28, 2023
With many medicines from Pfizer’s Rocky Mount, North Carolina, production plant relegated to an emergency ordering list following a devastating tornado last month, hospitals and government health o | With many medicines from Pfizer’s Rocky Mount, North Carolina, production plant relegated to an emergency ordering list following a devastating tornado last month, hospitals are likely eager for the massive injectables facility to restart production.
European Pharmaceutical Review
AUGUST 28, 2023
Novartis has announced that Leqvio ® (inclisiran) , the first and only small interfering RNA (siRNA) therapy indicated to reduce low-density lipoprotein cholesterol (LDL-C), has demonstrated promising long-term results. This is based on three-year follow up data from a Phase III trial, presented at the European Society of Cardiology (ESC) Congress 2023.
MedCity News
AUGUST 28, 2023
Regard — a startup selling an AI co-pilot that helps clinicians diagnose medical conditions — announced a new partnership to add to its technology’s capabilities. The company is teaming up with OpenAI to release new chatbot functionalities built on OpenAI’s large language model GPT-4.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmaVoice
AUGUST 28, 2023
In the high-growth but competitive field of migraine treatments, CGRP drugs have changed the game — but the search is still on for more options.
Pharmaceutical Technology
AUGUST 28, 2023
Specialised Therapeutics has entered into a licensing agreement with Treeway for TW001, designed for treating amyotrophic lateral sclerosis.
MedCity News
AUGUST 28, 2023
Abcam’s acquisition comes two months after its board announced the exploration of strategic alternatives that could include the sale of the company. Danaher beat out at least 20 companies that were potential buyers of the life sciences tools and antibody development firm.
PharmaVoice
AUGUST 28, 2023
As Novo Nordisk’s drug Wegovy sways Denmark’s economy, we're examining wider implications for the weight loss market.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
MedCity News
AUGUST 28, 2023
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Clarify Health
AUGUST 28, 2023
In recent years, payment models have transformed considerably, shifting from volume-based models to more value-driven models emphasizing quality of care. This shift aims to incentivize healthcare providers to focus on patient outcomes rather than just the quantity of services provided. Integral to this new model is claims adjudication, a pivotal process that determines the validity of healthcare claims.
Quantified
AUGUST 28, 2023
While remote work was a quick solution to pandemic-related quarantining and social distancing efforts, it reflected a then-already emerging trend in the workplace toward hybrid and WFH options. Today, it’s become fully normalized, and 85% of managers expect remote work to be here to stay permanently. For many businesses, it’s time to stop debating if remote and hybrid work will continue and focus on how remote work can be as productive and profitable as possible.
Legacy MEDSearch
AUGUST 28, 2023
Stimlabs LLC, (“StimLabs”), a leader in regenerative medicine, announced the launch of Relese , a fenestrated dehydrated complete human placental membrane (dCHPM) allograft for chronic and acute wounds. As the latest solution in StimLabs’ growing suite of dCHPM allografts, Relese provides a selective barrier with channels that allow wound fluid to drain while also protecting the wound from the surrounding environment.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Penrod
AUGUST 28, 2023
ISO 27001 is more than just a certificate. It reinforces our commitment to being your a trusted partner for the leaders in healthcare.
Pharmaceutical Technology
AUGUST 28, 2023
GC Biopharma has signed a memorandum of understanding (MOU) with Eubiologics to jointly manufacture oral cholera vaccine, Euvichol.
Pharmacy Times
AUGUST 28, 2023
Advanced technology can automate many pharmacovigilance tasks to build workflow efficiencies, reduce manual intervention, and free up team members for more strategic activities.
Pharmaceutical Technology
AUGUST 28, 2023
Pharmaceutical firm Phebra has reached a new six-year collaboration agreement with Australia’s University of Wollongong (UOW)
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmacy Times
AUGUST 28, 2023
Although the patient demographics are similar for the 3 categories of hemolytic reactions with intravenous immunoglobulin, the reaction with delayed hemolytic transfusion reactions was highest compared to the other 2 hemolytic reactions.
Pharmaceutical Technology
AUGUST 28, 2023
Novartis division Sandoz has concluded the acquisition of global brand rights for the antifungal agent Mycamine from Astellas.
Pharmacy Times
AUGUST 28, 2023
Perhaps the most significant development in the pharmaceutical industry in decades, crops of biosimilars are being approved and are ready for distribution. What lies next, in terms of legislation and the impact on pharmacists, remains to be seen.
Pharmaceutical Technology
AUGUST 28, 2023
The Janssen has submitted a sBLA to the US FDA for RYBREVANT plus chemotherapy for non-small cell lung cancer (NSCLC).
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
246 
Let's personalize your content